Key facts: NOC Q3 sales $11.1B; Guggenheim Keeps Buy
Northrop Grumman (NOC) reported Q3 sales of $11.1B, up 7% YoY, with EPS of $7.89. The company raised its 2026 EPS guidance to $29.35–$29.75 and expects 2027 sales growth of 5%–7%. Guggenheim maintained a Buy rating and $640 price target, citing strong performance.
How this was made

The 30-second read
Why it matters
The raised EPS guidance and buy rating suggest a positive market reaction.
Market read
First report of Q3 results and upgraded guidance, likely to move the stock in early trading.
What to watch
Backlog size and award pipeline may not translate into near‑term revenue, limiting upside.
Background
Northrop Grumman's Q3 earnings and guidance release.
Ticker impact
Northrop Grumman reported Q3 sales of $11.1B, EPS $7.89 and raised 2026 EPS guidance to $29.35‑$29.75.
upside pressure as investors price in higher EPS guidance
The company increased its EPS guidance and received a buy rating with a $640 target, indicating confidence in future performance.
Market effects
Defense sector may see broader optimism from Northrop's raised guidance.
U.S. defense stocks could benefit in early trading.
Potential ripple to global aerospace and defense suppliers.
Counterpoint
If the guidance is overly optimistic, the stock could face disappointment if future quarters miss expectations.
Key entities
- companyNorthrop Grumman
U.S. defense contractor
- analystGuggenheim
Maintained Buy rating with $640 price target



